View of Efficacy And Safety Of Sodium-Glucose Cotransporter-2 (Sglt2) And Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Combination Therapy In Patients With Type 2 Diabetes Inadequately Controlled By Metformin

Return to Article Details Efficacy And Safety Of Sodium-Glucose Cotransporter-2 (Sglt2) And Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Combination Therapy In Patients With Type 2 Diabetes Inadequately Controlled By Metformin Download Download PDF